Curis Provides Fourth Quarter 2023 Business Update [Yahoo! Finance]
Curis, Inc. (CRIS)
Last curis, inc. earnings: 11/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.curis.com
Company Research
Source: Yahoo! Finance
Cash runway into 2025 Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass. Feb. 8, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and financial results for the quarter ended December 31, 2023 Operational Highlights In December at the 65 th American Society of Hematology Annual Meeting and Exposition (ASH), the Company presented data from both the TakeAim Lymphoma and TakeAim Leukemia studies. A summary of key findings of the data that were presented from the on-going studies are as follows: TakeAim Lymphoma – data for patients with primary CNS lymphoma (PCNSL) who had failed prior BTKi therapy showed 3 of 5 evaluable patients achieved Complete Response (CR). TakeAim Leukemia – data for patients with relapsed/refractory (R/R) AML with a FLT3 mutation who received In addition to the pre
Show less
Read more
Impact Snapshot
Event Time:
CRIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRIS alerts
High impacting Curis, Inc. news events
Weekly update
A roundup of the hottest topics
CRIS
News
- Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Curis to Present at Upcoming Healthcare Conferences in April [Yahoo! Finance]Yahoo! Finance
- Curis to Present at Upcoming Healthcare Conferences in AprilPR Newswire
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)PR Newswire
CRIS
Earnings
- 2/8/24 - Miss
CRIS
Sec Filings
- 4/15/24 - Form SC
- 4/15/24 - Form EFFECT
- 4/10/24 - Form ARS
- CRIS's page on the SEC website